Results 11 to 20 of about 3,126,496 (202)

Emerging treatments for essential thrombocythemia

open access: yesJournal of Blood Medicine, 2011
Steven Okoli, Claire HarrisonDepartment of Haematology, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, UKAbstract: In 1934, Epstein and Goedel used the term hemorrhagic thrombocythemia to describe a disorder ...
Okoli S, Harrison C
doaj   +2 more sources

Essential thrombocythemia: a rare disease in childhood

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2013
Essential thrombocythemia is an acquired myeloproliferative disorder characterized by the proliferation of megakaryocytes in bone marrow, leading to a persistent increase in the number of circulating platelets and thus increasing the risk for thrombotic ...
Julia Maimone Beatrice   +1 more
doaj   +2 more sources

Essential Thrombocythemia

open access: yesSiriraj Medical Journal, 2002
This is a review of twelve cases of Essential Thrombocythemia at Suratthani Hospital, aged between 48 to 87 years old, 6 male and 6 female. The initial clinical presentations were as follows: 2 asymptomatic cases (incidentally found on routine CBC check ...
Kanchanee Janwanitsthaporn
doaj   +1 more source

Acute megakaryoblastic transformation from essential thrombocythemia

open access: yesHuman Pathology: Case Reports, 2017
Essential thrombocythemia (ET) is a Philadelphia chromosome-negative myeloproliferative neoplasm characterized by sustained thrombocytosis. Its transformation into acute leukemia is a rare event (5% at 20 years).
Tariq M. Roshan   +3 more
doaj   +2 more sources

The role of oxidative stress in essential thrombocythemia [PDF]

open access: yesArchives of the Balkan Medical Union, 2018
In patients with myeloproliferative neoplasms (MPNs), including essential thrombocythemia, current studies have demonstrated a JAK2V617F-dependent reactive oxygen species (ROS) elevation partially mediated by a decrease in catalase expression associated ...
Cornel Moisă   +6 more
doaj   +1 more source

Essential thrombocythemia and acute myocardial infarction treated with rescue coronary angioplasty

open access: yesArquivos Brasileiros de Cardiologia, 1999
A 48-year-old man with essential thrombocythemia suffered an extensive anterior acute myocardial infarction; this is a rare association. A pharmacological thrombolysis was performed, without success.
Antonio Esteves Fº   +4 more
doaj   +2 more sources

Diagnosis and Management of Essential Thrombocythemia: A Comprehensive Review [PDF]

open access: yesDocumenta Haematologica
Myeloproliferative neoplasms, including essential thrombocythemia, are characterized by clonal proliferations of hematopoietic stem cells, leading to an increase in mature myeloid lineage cells.
Sandra LAZAR   +6 more
doaj   +3 more sources

Exposure-Response Analyses of Ropeginterferon Alfa-2b in Essential Thrombocythemia. [PDF]

open access: yesJ Clin Pharmacol
Abstract Ropeginterferon alfa‐2b is a new‐generation interferon therapy for the treatment of myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET). This investigation was designed to characterize its population pharmacokinetics–pharmacodynamics (PopPK‐PD) and delineate exposure–response (E‐R) relationships in ET. A population PK
Qin A   +20 more
europepmc   +2 more sources

The Roles of Genetic and Epigenetic Abnormalities in Essential Thrombocythemia. [PDF]

open access: yesGenes (Basel)
Essential thrombocythemia (ET) is a Ph(-) myeloproliferative neoplasm characterized by elevated platelet counts. Patients most often have one of the three following driver mutations: JAK2, MPL, or CALR.
Strzała D   +7 more
europepmc   +2 more sources

Pediatric Essential Thrombocythemia With a Novel <i>CALR</i> Mutation: A Case Report. [PDF]

open access: yesEJHaem
ABSTRACT Pediatric essential thrombocythemia (ET) is extremely rare and frequently lacks identifiable driver mutations. We report a case of a 5‐year‐old male with ET harboring a novel CALR exon 9 frameshift mutation complicated by acquired von Willebrand syndrome.
Tsuji K   +10 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy